The diabetic shoes market size is projected to be valued at USD 8.6 billion in 2023, and is expected to rise to USD 16.0 billion by 2033. The sales of diabetic shoes are expected to expand at a significant CAGR of 6.4% during the forecast period.
Various Factors Propelling the Demand for Diabetic Shoes are
To minimize the danger of the consequences of diabetic foot ulcers and limb amputation, individuals are moving their choice toward preventative care, as the burden of diabetes affects many people worldwide.
The World Health Organization reports that more than 50% of diabetics who are at risk for limb injuries also have peripheral neuropathies, which has the additional consequence of raising mortality rates globally.
Since more diabetic patients are becoming aware of the benefits of wearing diabetic footwear, the market for diabetic shoes is expanding significantly on a global scale. Customized and predesigned diabetic shoes with certain key features are growing in popularity among diabetic patients worldwide.
The global population's unhealthy and hectic lifestyle is further boosting the demand for different medical footwear. In addition, the rising elderly population worldwide is probably going to elevate market growth shortly.
Customers are now being encouraged to purchase diabetic shoes and other diabetic products online, due to the existence of an efficient online platform by key players and increased internet penetration.
Long-term market expansion is strongly supported by expanding infrastructure facilities associated with distribution outlets and specialty shoe shops.
As a result of advancements in the protective footwear market and increased research and development activities to combat diabetic foot ulcers, the global medical footwear market is likely to grow significantly during the forecast period.
Several government and non-government organizations are researching to better understand diabetic foot ulcers and their patterns. For example, the National Institutes of Health-funded Diabetic Foot Consortium (DFC) was established in 2020 to study diabetic foot ulcers.
The development of personalized and stylish diabetic footwear by leading manufacturers to keep up with the current fashion trend is playing a significant role in the market's expansion.
| Attribute | Details |
|---|---|
| Diabetic Shoes Market Estimated Size (2023) | USD 8.6 billion |
| Diabetic Shoes Market CAGR (2023 to 2033) | 6.4% |
| Diabetic Shoes Market Forecasted Size (2033) | USD 16.0 billion |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global demand for diabetic shoes is predicted to witness a healthy CAGR of 6.4% between 2023 and 2033, in comparison to the 4.1% CAGR registered from 2017 to 2022. Growth in the diabetic shoes market is attributed to the increase in the prevalence of diabetes, growing awareness about the availability of medical footwear products across developing regions, increasing need for better foot care, new product launches, and favorable government support.
Diabetic shoes are unique footwear products designed to preserve diabetic feet, as well as to reduce skin breakdown due to neuropathy, impaired mobility, and deformities. These diabetic shoes have flexible uppers and an extra-thickness design for a pressure-free fit. They provide better motion control, prevent skin breakdown, promote circulation, reduce calluses formation, and thus eliminate the risk of foot problems in high-pressure areas of the foot.
The rapid surge in cases of diabetes and diabetic ulcers is a significant factor boosting growth of the market. According to the International Diabetes Federation (IDF), diabetic foot and lower limb complications have become serious health problems, affecting 40 to 60 million people with diabetes globally.
These health conditions (chronic ulcers and amputations) significantly reduce the quality of life and increase the risk of early death. To counter this and minimize the risk of infections, people use preventive healthcare products like diabetic shoes. This is likely to continue to expand the global diabetic shoes market size during the forecast period.
The global market for diabetic shoes is divided into categories based on product type, including dress shoes, walking shoes, and running shoes. Due to the quick adoption of diabetic dress shoes by customers, the dress shoes segment had a prominent share of all of these at 43.4% in 2021, and is anticipated to expand at a significant rate throughout the forecast period.
As the market is significantly expanding, diabetic shoes are becoming well-liked among working professionals in industrialized nations. Additionally, these shoes offer additional defense against foot injuries, lowering the risk of fungus infections. It is anticipated that the launch of diabetic shoes made of cutting-edge materials like cotton, nylon, and leather is likely to present manufacturers with lucrative business opportunities.
Based on end-user, women are the front-runner of the segment with a growth rate of 5.8%. Women typically have higher SHBG levels than men do, and low SHBG concentrations may put women at even great risk for developing diabetes than men do.
Women are more likely to get diabetes, hence they spend money on caring for and maintaining their bodies. In addition, it is anticipated that during the forecast period, women in developing regions are more likely to become aware of diabetes and its effects on their health due to rising awareness and campaigns.
Given the high prevalence of both type 1 and type 2 diabetes among the population in the United States, as well as the high consumption of such products in the region, the North America market holds a prominent share of the global market. According to information provided by the United States Department of Health and Human Resources, 34.2 million Americans had diabetes as of 2018.
Additionally, the growing consciousness of people about health and hygiene, as well as healthcare product spending, contribute to the region's higher sales of diabetic shoes.
| United States Market Size (USD million/billion) by End of Forecast Period (2033) | USD 5.7 billion |
|---|---|
| United States Market Absolute Dollar Growth (USD million/billion) | USD 2.5 billion |
| CAGR % 2017 to 2022 | 9.7% |
| CAGR % 2023 to End of Forecast (2033) | 6.1% |
With the prevalence of high levels of health awareness among the populace, the availability of a variety of diabetic shoes, the growth of government initiatives to lessen the burden of diabetes, and the significant presence of top diabetic shoe manufacturers, sales of diabetic shoes are predicted to increase across the United Kingdom at a moderate CAGR of 5.4% during the assessment period.
Around 3.9 million people in the United Kingdom had diabetes in 2019, and 90% of those had type 2 diabetes, according to Diabetes United kingdom, a British diabetic association.
The market for diabetic footwear shoes in the United Kingdom is also likely to see growth opportunities due to rising consumer expenditure on diabetic shoe purchases made online and the growing demand for diabetic shoes for women.
| United Kingdom Market Size (USD million/billion) by End of Forecast Period (2033) | USD 673.3 million |
|---|---|
| United Kingdom Market Absolute Dollar Growth (USD million/billion) | USD 277.1 million |
| CAGR % 2017 to 2022 | 8.8% |
| CAGR % 2023 to End of Forecast (2033) | 5.4% |
A hectic lifestyle and changing eating habits have led to an increase in the prevalence of diabetes and obesity. Growing consumer knowledge of diabetes and related illnesses is predicted to open up significant business prospects in the region's developing nations, including China and India.
India region has experienced a significant increase, which is related to the high number of footwear items imported and shows rising demand for diabetic shoes in the area. The World Bank Organization reports that the value of India's footwear imports from Italy in 2018 was USD 23.07 million. The population's increasing interest in sports and leisure activities is another factor boosting the need for diabetic shoes in the area.
Due to the prevalence of type 2 diabetes, which ranges from about 2% in the People's Republic of China to a wide spectrum of adult populations, several leading businesses are investing in the Asia Pacific area. The diabetic shoes market is anticipated to expand in other areas as well, due to an increase in the elderly population and the introduction of better diabetic footwear.
| China Market Size (USD million/billion) by End of Forecast Period (2033) | USD 1.1 billion |
|---|---|
| China Market Absolute Dollar Growth (USD million/billion) | USD 492.4 million |
| CAGR % 2017 to 2022 | 9.3% |
| CAGR % 2023 to End of Forecast (2033) | 5.8% |
The top competitors in the diabetic footwear industry have made it a priority to offer consumers specialized solutions as one of their primary methods to capture a sizeable portion of the market. The leading players have also benefited from strategies like product launches and acquisitions to increase their market position in the diabetic footwear industry.
Latest Developments:
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Asics, Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, DJO, LLC (Dr. Comfort), Advance Diabetic Solution, Dr. Zen Products, Inc., and Sensoria Health
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.4% from 2023 to 2033 |
| Base Year of Estimation | 2023 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD billion and Volume in Units and F-CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Product Type, Patient Type, Width, Sales Channel, End User, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Asics; Drewshoe; Incorporated; Orthofeet Inc.; DARCO International, Inc.; Clearwell Mobility Company; Supad; Aetrex Worldwide, Inc.; Gravity Defyer Corp.; Kinetec Medical Products Ltd; Horng Shin Footwear Co.; Watts Footwear; DJO, LLC (Dr. Comfort); Advance Diabetic Solution; Dr. Zen Products, Inc.; and Sensoria Health |
| Customization & Pricing | Available upon Request |
The worldwide diabetic shoes market is expected to be valued at US$ 8.6 billion in 2023.
Asics, Drewshoe, Incorporated, and Orthofeet Inc., are the leading diabetic shoes industry players.
The diabetic shoes industry is set to surge at a CAGR of 6.4% from 2023 to 2033.
United States is anticipated to generate US$ 5.7 billion revenue by 2033.
Rising life expectancy and greater awareness of obesity's risks are expected to boost product demand.
| Estimated Market Size (2024E) | USD 64.5 billion |
|---|---|
| Projected Market Value (2034F) | USD 117.7 billion |
| Value-based CAGR (2024 to 2034) | 6.2% |
Explore Therapeutic Device Insights
View Reports
Diabetic Shoes Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
